Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP2R3A | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
mRNA | ARHGAP25 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0003 |
mRNA | SEC11C | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
mRNA | ANXA2 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
mRNA | EPS8L3 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0003 |
mRNA | FAM160B2 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | SCG3 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
mRNA | CABP4 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0003 |
mRNA | ATP6V1C2 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
mRNA | NFATC2IP | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |